Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-023-08469-3.pdf
Reference100 articles.
1. Yabroff KR, Wu XC, Negoita S, Stevens J, Coyle L, Zhao J et al (2022) Association of the COVID-19 pandemic with patterns of Statewide Cancer Services. J Natl Cancer Inst 114(6):907–909. https://doi.org/10.1093/jnci/djab122
2. Xia C, Dong X, Li H, Cao M, Sun D, He S et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135(5):584–590. https://doi.org/10.1097/cm9.0000000000002108
3. Pham D-V, Park P-H (2021) Tumor metabolic reprogramming by Adipokines as a critical driver of Obesity-Associated Cancer Progression. Int J Mol Sci 22(3):1444. https://doi.org/10.3390/ijms22031444
4. asl MS, Azimnasab-sorkhabi P, Abolfathi A-A, aghdam YH (2020) Identification of nucleotide polymorphism within the NeuroD1 candidate gene and its association with type 1 diabetes susceptibility in iranian people by polymerase chain reaction-restriction fragment length polymorphism. J Pediatr Endocrinol Metab 33(10):1293–1297. https://doi.org/10.1515/jpem-2019-0441
5. Azimnasab-sorkhabi P, Soltani-asl M, Kfoury Junior J, Algenstaedt P, Moammadzadeh Ghosi F, Hashemi aghdam Y The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran. Annals of Human Biology. https://doi.org/10.1080/03014460.2022.2134453
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Landscape of unconventional γδ T cell subsets in cancer;Molecular Biology Reports;2024-01-30
2. The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells;Immunologic Research;2023-12-28
3. Developing reliable classification of dual IDO1/TDO inhibitors using data fusion and majority voting;Journal of Biomolecular Structure and Dynamics;2023-11-03
4. Blockade of PD‐1 and CTLA‐4: A potent immunotherapeutic approach for hepatocellular carcinoma;BioFactors;2023-11-03
5. Skin Cancer Microenvironment: What We Can Learn from Skin Aging?;International Journal of Molecular Sciences;2023-09-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3